The phosphoinositol 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) (PI3K/AKT/mTOR) pathway is also a target in overcoming taxane resistance in ovarian cancer. Here, MTOR is linked to ovarian carcinoma.